wEight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD-HES linked cohort study.
Barbara TorlinskaJonathan M HazlehurstKrishnarajah NirantharakumarGraham Neil ThomasJulia R PriestleySamuel John FinnikinPhilip SaundersKeith R AbramsKristien BoelaertPublished in: BMJ open (2021)
The study will bring new knowledge on the risk of developing obesity, cardiometabolic morbidity and mortality following treatment for hyperthyroidism to inform clinical practice and public health policies. The results will be disseminated via open-access peer-reviewed publications and directly to the patients and public groups (Independent Scientific Advisory Committee protocol approval #20_000185).
Keyphrases
- public health
- end stage renal disease
- clinical practice
- healthcare
- weight loss
- randomized controlled trial
- chronic kidney disease
- newly diagnosed
- ejection fraction
- metabolic syndrome
- insulin resistance
- type diabetes
- weight gain
- physical activity
- peritoneal dialysis
- body mass index
- minimally invasive
- prognostic factors
- risk factors
- human health
- combination therapy
- replacement therapy
- drug administration